Home/Filings/4/0001123292-20-000461
4//SEC Filing

Heller Kevin N. 4

Accession 0001123292-20-000461

CIK 0001661059other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:37 PM ET

Size

5.3 KB

Accession

0001123292-20-000461

Insider Transaction Report

Form 4
Period: 2020-02-28
Heller Kevin N.
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-02-28+100,050100,050 total
    Exercise: $41.76Exp: 2030-02-27Common Stock (100,050 underlying)
Footnotes (1)
  • [F1]One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021.

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1
  • filerCIK 0001775716

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:37 PM ET
Size
5.3 KB